Commodore Capital’s Arcellx ACLX Stock Holding History

Commodore Capital’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-591,437	Closed	-$18.3M	–	33
2022 Q4	$18.3M	Buy	+591,437	New	+$13.6M	2.76%	14

Other funds holding ACLX

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Commodore Capital's ACLX Position: Q1 2023 in Review

Commodore Capital sold out of Arcellx (ACLX) in Q1 2023, closing a stake of 591,437 shares — an estimated $18.3M sold.

Commodore Capital first reported a position in ACLX in Q4 2022 and held it in 1 quarter. The position peaked at $18.3M in Q4 2022. 117 funds tracked by Wall St. Rank hold ACLX as of Q1 2023.

Commodore Capital reported no remaining Arcellx position as of Q1 2023 after selling out during the quarter.
Commodore Capital sold 591,437 Arcellx shares in Q1 2023, an estimated $18.3M.
Commodore Capital first reported a position in Arcellx in Q4 2022 and held it in 1 quarter.
Commodore Capital's Arcellx position peaked at $18.3M in Q4 2022.
117 funds tracked by Wall St. Rank held Arcellx as of Q1 2023.

Based on Commodore Capital's 13F filing for Q1 2023, filed 15 May 2023.